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General: All reactions were carried out in flame-dried glassware under Ar. All solvents were purified by distillation 
over the appropriate drying agents and were transferred under Ar. IR: Nicolet FT-7199 spectrometer, wavenumbers 
in cm
−1
. MS (EI): Finnigan MAT 8200 (70 eV), ESIMS: Finnigan MAT 95, accurate mass determinations: Bruker 





chemical shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. The solvent signals were used as 
references and the chemical shifts converted to the TMS scale.  








, 7 and 9
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were prepared according to literature procedures. Gold (I) isonitriles 1a and 1b were prepared using the method 
described by Hashmi et. al. in quantitative yields
6





General procedure for AAYC-gold complexes bearing phosphorus ylides: 
 
 
In a typical procedure, Gold (I) isonitrile 1 is suspended in toluene (0.024M) followed by addition of ylide 2 
at the indicated temperature. After stirring the reaction for the referred time, the mixture was allowed to reach room 
temperature and the solvents filtered out. The remaining white solid thus obtained was then washed with small 
portions of pentane and dried under vacuum. 
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 Compound 4a: Following the general procedure described above, a mixture of 
phenylisocyanide gold (I) chloride 1a (40 mg, 0.12 mmol) and 1-(Triphenylphosphoranylidene)-
2-propanone 2a (38 mg, 0.12 mmol) afforded pure 4a (66 mg.  85%) after a reaction time of 3 
d at room temperature. 
1
H-NMR (400 MHz, CD2Cl2)  14.54 (s, 1 H), 7.97-7.92 (m, 6 H), 7.72-7.69 (m, 3 H), 7.65-
7.59 (m, 8 H), 7.34-7.31 (m, 2 H), 7.24-7.21 (m, 1 H), 1.47 (s, 3 H) ppm. 
13
C-NMR (101 MHz, 
CD2Cl2) = 200.9 (d, JC-P = 36.0 Hz), 195.3 (d, JC-P = 24.0 Hz), 144.1, 134.5 (d, JC-P = 8.6 Hz), 133.5 (d, JC-P = 3.0 
Hz), 129.8 (d, JC-P = 12.3 Hz), 129.1, 126.6, 125.8 (d, JC-P = 91.6 Hz), 123.7, 93.0 (d, JC-P = 124.9 Hz), 31.7 (d, JC-P 
= 2.3 Hz) ppm. 
31
P-NMR (162 MHz, CD2Cl2) = 19.6 ppm. HRMS calcd. for C28H24NOAuClPNa: 676.084174; 
found 676.084426. IR (neat) ~ = 680, 690, 706, 721, 736, 749, 756, 875, 901, 983, 998, 1024, 1052, 1095, 1133, 




Compound 4b: Following the general procedure described above, a mixture of 
phenylisocyanide gold (I) chloride 1a (41 mg, 0.12 mmol) and the phosphorus ylide 2b (45 mg, 
0.12 mmol) afforded pure 4b (62 mg, 74%)  after a reaction time of 1 d at 35 °C. 
1
H-NMR (400 MHz, CD2Cl2) = 12.67 (s, 1 H), 7.89-7.84 (m, 6 H), 7.67-7.63 (m, 5 H), 7.58-
7.53 (m, 6 H), 7.34-7.30 (m, 2 H), 7.23-7.19 (m, 1 H), 3.73 (q, J = 7.2 Hz, 2 H), 0.59 (t, J = 7.2 
Hz, 3 H) ppm. 
13
C-NMR (101 MHz, CD2Cl2) = 200.6 (d, JC-P  = 35.9 Hz), 168.8 (d, JC-P  = 17.2 
Hz), 144.4, 134.1 (d, JC-P  = 9.0 Hz), 133.0 (d, JC-P  = 2.6 Hz), 129.4 (d, JC-P  = 12.7 Hz), 129.1, 126.3, 126.2(d, JC-P  
= 94.0 Hz), 123.4, 79.4 (d, JC-P  = 134.4 Hz), 60.0, 13.6 ppm. 
31
P-NMR (162 MHz, CD2Cl2)  22.0 ppm. HRMS 
calcd. for C29H26NO2AuClPNa: 706.094742; found 706.095558. IR (neat) 
~
= 688, 681, 698, 710, 748, 760, 799, 
819, 849, 905, 937, 997, 1024, 1071, 1081, 1103,1156, 1164, 1185, 1197, 1233, 1292, 1336, 1368, 1392, 1436, 




Compound 4c: Following the general procedure described above, a mixture of 
phenylisocyanide gold (I) chloride 1a (23 mg, 0.07 mmol) and the phosphous ylide  2c (21 mg, 
0.07 mmol) afforded pure 4c (38 mg, 88%)  after a reaction time of 3 d at 35 °C. 
1
H-NMR (400 MHz, CD2Cl2) = 8.89 (s, 1 H), 7.83-7.75 (m, 9 H), 7.71-7.69 (m, 2 H), 7.69-
7.61 (m, 6 H), 7.38-7.34 (m, 2 H), 7.28-7.24 (m, 1 H) ppm. 
13
C-NMR (101 MHz, CD2Cl2) = 
201.9 (d, JC-P = 35.9 Hz), 143.0, 134.8 (d, JC-P  = 9.8 Hz), 134.4 (d, JC-P  = 2.9 Hz), 129.8 (d, JC-
P  = 13.0 Hz), 129.3, 126.8, 123.1, 122.9 (d, JC-P  = 94.1 Hz), 117.8 (d, JC-P  = 22.1 Hz), 60.1 (d, JC-P  = 154.6 Hz) 
ppm. 
31
P-NMR (162 MHz, CD2Cl2)  21.8 ppm. HRMS calcd. for C27H21N2AuClPNa: 659.068858; found 
659.069049. IR (neat) ~ = 687, 715, 727, 748, 758, 788, 850, 900, 923, 996, 1026, 1073, 1102, 1120, 1190, 1225, 




Compound 4d: Following the general procedure described above, a mixture of 
phenylisocyanide gold (I) chloride 1a (23 mg, 0.07 mmol) and phosphorus ylide 2d (24 mg, 
0.07 mmol) afforded pure 4d (38 mg, 81%)  after a reaction time of 6 h at 35 °C. 
1
H-NMR (400 MHz, CD2Cl2) = 7.98 (s, 1 H), 7.85-7.80 (m, 6 H), 7.69-7.65 (m, 3 H), 7.61-
7.53 (m, 8 H), 7.29-7.25 (m, 2 H), 7.14-7.06 (m, 1 H), 2.88 (s, 6 H) ppm. 
13
C-NMR (101 MHz, 
CD2Cl2) = 188.9 (d, JC-P  = 32.0 Hz), 167.8 (d, JC-P  = 19.1 Hz), 144.4, 134.6 (d, JC-P  = 9.3 Hz), 133.4 (d, JC-P  = 2.9 
Hz), 129.3 (d, JC-P  = 12.4 Hz), 129.0, 125.1 (d, JC-P = 92.0 Hz), 125.0, 122.4, 86.1 (d, JC-P  = 132.3 Hz), 37.0 ppm. 
31
P-NMR (162 MHz, CD2Cl2) 18.1 ppm. HRMS calcd. for C29H27N2OAuClPNa: 705.110727; found 705.110773. 
IR (neat) ~ = 691, 729, 144, 756, 841, 900, 937, 998, 1027, 1048, 1070, 1098, 1158, 1188, 1215, 1271, 1304, 




Compound 4e: Following the general procedure described above, a mixture of phenylisocyanide gold (I) chloride 
1a (89 mg, 0.26 mmol) and phosphorus ylide 2e (94 mg, 0.26 mmol) afforded pure 4e (180 mg, 98%)  after a 
reaction time of 6 h at 35 °C. 
1
H-NMR (400 MHz, CD2Cl2) = 9.77 (s, 1 H), 8.45 (d, J = 4.6 Hz, 1H), 7.82  (dd, J = 12.1, 8.1 
Hz, 6 H), 7.62-7.58 (m, 5 H), 7.52-7.47 (m, 6 H), 7.30-7.22 (m, 3 H), 7.06 (t, J = 7.1 Hz, 1H), 
6.93-6.90 (m, 1 H), 6.81 (d, J = 7.9 Hz, 1 H) ppm. 
13
C-NMR (101 MHz, CD2Cl2) = 189.6 (d, 
JC-P  = 35.7 Hz), 156.4 (d, JC-P  = 20.1 Hz), 149.6, 144.5, 136.3, 134.7 (d, JC-P  = 9.1 Hz), 
133.0 (d, JC-P  = 2.6 Hz), 129.2 (d, JC-P  = 12.1 Hz), 128.8, 126.8 (d, JC-P  = 3.0 Hz), 126.2 (d, 
JC-P = 91.8 Hz), 124.4, 121.7, 120.8,  87.9 (d, JC-P = 134.4 Hz) ppm. 
31
P-NMR (162 MHz, 
CD2Cl2) = 20.0 ppm. HRMS calcd. for C31H25N2AuClPNa: 711.100164; found 711.100454. 
IR (neat) ~ = 688, 711, 742, 793, 862, 900, 997, 1017, 1051, 1098, 1154, 1183, 1263, 1312, 1379, 1425, 1435, 




Compound 4f: Phenylisocyanide gold (I) chloride 1a (44 mg, 0.12 mmol) is added to a cooled 
solution of the phosphorus ylide 2f (43 mg, 0.12 mmol) at -78 °C. After 2 h, it was allowed to 
warm up to room temperature overnight. Filtration of the obtained suspension afforded a white 
solid, which contains both 4f and the side product 3f. Consecutive crystallizations (3 times) in 
DCM/pentane allowed the isolation of pure 4f (4 mg) in 5 % yield. 
1
H-NMR (400 MHz, CD2Cl2) 
 7.71-7.66 (m, 5 H), 7.64-7.59 (m, 3 H), 7.52-7.45 (m, 9 H), 7.30 (s, 1 H), 7.22-7.13 (m,5 H), 
7.06-6.70 (m, 3 H) ppm. 
13
C-NMR (101 MHz, CD2Cl2) = 187.1 (d, JC-P  = 37.7 Hz), 144.5, 
134.8 (d, JC-P  = 9.0 Hz), 134.0 (d, JC-P  = 3.8 Hz), 133.1 (d, JC-P  = 2.8 Hz), 133.1 (d, JC-P  = 2.8 Hz), 132.3 (d, JC-P  = 
9.9 Hz), 129.6 (d, JC-P  = 1.7 Hz), 129.1 (d, JC-P  = 12.3 Hz), 129.0 (d, JC-P  = 12.1 Hz), 128.9, 127.9 (d, JC-P  = 2.3 
Hz), 125.8 (d, JC-P  = 91.1 Hz), 124.0, 121.2,  88.9 (d, JC-P  = 132.1 Hz) ppm. 
31
P-NMR (162 MHz, CD2Cl2) = 21.0 
ppm. HRMS calcd. for C31H31N2OAuClPNa: 710.104912; found 710.105881. IR (neat) 
~
= 689, 704, 716,l 744, 784, 
800, 853, 887, 913, 996, 1009, 1027, 1071, 1098, 1159, 1220, 1261, 1305, 1326, 1372, 1433, 1444, 1480, 1493, 




Compound 4g: Following the general procedure described above, a mixture of 2,6-
dimethyl-phenylisocyanide gold (I) chloride 1b (100 mg, 0.28 mmol) and phosphorus ylide 
2a (88 mg, 0.28 mmol) afforded pure 4g (54 mg, 30%)  after a reaction time of 3 d at 50 °C. 
1
H-NMR (400 MHz, CD2Cl2)  13.70 (s, 1 H), 7.97-7.92 (m, 6 H), 7.73-7.68 (m, 3 H), 
7.64-7.58 (m, 6 H), 7.13-7.06 (m, 3 H), 2.26 (s, 6 H), 1.48 (s, 3 H) ppm. 
13
C-NMR (101 
MHz, CD2Cl2) = 206.6 (d, JC-P  = 34.8 Hz), 195.0 (d, JC-P  = 28.0 Hz), 142.6, 135.0, 134.6 
(d, JC-P  = 8.6 Hz), 133.6 (d, JC-P  = 2.9 Hz), 129.7 (d, JC-P  = 12.4 Hz), 128.4, 127.6, 125.9 (d, JC-P  = 92.0 Hz), 91.1 
(d, JC-P  = 124.3 Hz), 31.6 (d, JC-P  = 2.0 Hz), 19.1 ppm. 
31
P-NMR (162 MHz, CD2Cl2) = 20.5 ppm. HRMS calcd. for 
C30H28NOAuClPNa: 704.115849; found 704.115049. IR (neat) 
~
= 682, 693, 709, 720, 734, 755, m768, 781, 842, 




Compound 4h: Following the general procedure described above, a mixture of 2,6-
dimethyl-phenylisocyanide gold (I) chloride 1b (46 mg, 0.13 mmol) and phosphorus ylide 
2c (47 mg, 0.13 mmol) afforded after 4 d at 50 °C  a white solid that was further purified by 
crystallization from DCM : pentane. Thus, 4h was obtained in 37% yield (33 mg). 
1
H-NMR (400 MHz, CD2Cl2)  11.89 (s, 1 H), 7.89-7.83 (m, 6 H), 7.67-7.63 (m, 3 H), 
7.57-7.53 (m, 6 H), 7.14-7.07 (m, 3 H), 3.75 (q, J = 7.1 Hz, 2 H), 2.20 (s, 6H), 0.59 (t, J = 
7.1 Hz, 3 H) ppm. 
13
C-NMR (101 MHz, CD2Cl2) = 206.1 (d, JC-P  = 34.8 Hz), 168.8 (d, JC-P  = 16.9 Hz), 142.9, 
135.5, 134.2 (d, JC-P  = 9.2 Hz), 132.7 (d, JC-P  = 3.0 Hz), 129.3 (d, JC-P  = 12.3 Hz), 128.4, 127.5, 126.2 (d, JC-P  = 
93.6 Hz), 76.9 (d, JC-P  = 135.0 Hz), 59.6, 19.0, 13.6 ppm. 
31
P-NMR (162 MHz, CD2Cl2) = 22.4 ppm. HRMS calcd. 
for C31H30NO2AuClPNa: 734.126042; found 734.125744. IR (neat) 
~
= 683, 698, 709, 722, 748, 776, 802, 938, 997, 




Compound 4i: Following the general procedure described above, a mixture of 2,6-
dimethyl-phenylisocyanide gold (I) chloride 1b (86 mg, 0.24 mmol) and phosphorus ylide 
2c (71 mg, 0.24 mmol) afforded after 4 d at 50 °C  a white solid that was further purified by 
3 consecutive crystallizations from DCM : pentane. Thus, 4i was obtained in 25% yield (40 
mg). 
1
H-NMR (400 MHz, CD2Cl2)  8.29 (s, 1 H), 7.82-7.75 (m, 9 H), 7.65-7.61 (m, 6 H), 7.20-
7.17 (m, 1 H), 7.12-7.11 (m, 2 H), 2.36 (s, 6 H) ppm. 
13
C-NMR (101 MHz, CD2Cl2) = 207.0 (d, JC-P  = 29.5 Hz), 
141.2, 136.1, 134.7 (d, JC-P  = 9.9 Hz), 134.3 (d, JC-P  = 2.7 Hz), 129.6 (d, JC-P  = 13.1 Hz), 128.7, 128.4, 123.1 (d, 
JC-P  = 95.0 Hz), 117.8 (d, JC-P  = 22.2 Hz), 57.3 (d, JC-P = 154.6 Hz), 19.0 ppm. 
31
P-NMR (162 MHz, CD2Cl2) = 
22.1 ppm. HRMS calcd. for C29H25N2AuClPNa: 687.100159; found 687.100556. IR (neat) 
~
= 687, 697, 716, 749, 
780, 804, 907, 927, 952, 997, 1025, 1105, 1123, 1165, 1186, 1217, 1260, 1312, 1328, 1375, 1436, 1482, 1505, 




Compound 4j: 2,6-dimethyl-phenylisocyanide gold (I) chloride 1b (94 mg, 0.26 mmol) was 
added to a cooled solution of the phosphorus ylide 2d (90 mg, 0.26 mmol) in toluene (11 
ml) at -78 °C. After 2 h at this temperature, the reaction mixtures was allowed to reach 
room temperature overnight. Filtration of the obtained suspension afforded a white solid 
which was purified by recrystallization (3 times from DCM : pentane). Thus, 4j was 
obtained as colourless crystals (21 mg, 12%). 
1
H-NMR (400 MHz, CD2Cl2)  7.86-7.81 
(m, 6 H), 7.70-7.65 (m, 3 H), 7.58-7.54 (m, 6 H), 7.24 (s, 1 H), 7.14-7.07 (m,3 H), 2.95 (s, 6 H), 2.33 (s, 6 H) ppm. 
13
C-NMR (101 MHz, CD2Cl2) = 194.3 (d, JC-P  = 31.0 Hz), 168.0 (d, JC-P  = 19.2 Hz), 142.4, 136.6, 134.5 (d, JC-P  = 
9.1 Hz), 133.3 (d, JC-P  = 2.6 Hz), 129.2 (d, JC-P  = 12.3 Hz), 128.5, 127.6, 125.5 (d, JC-P  = 92.7 Hz), 82.1 (d, JC-P  = 
134.1 Hz), 37.0, 19.3 ppm.  
31
P-NMR (162 MHz, CD2Cl2) = 18.8 ppm. HRMS calcd. for C31H31N2OAuClPNa: 
733.142026; found 733.142583. IR (neat) ~ = 694, 712, 743, 755, 767, 854, 918, 946, 997, 1028, 1051, 1102, 




Compound 3e: Phenylisocyanide gold (I) chloride 1a (230 mg, 0.63 mmol) was added to a 
cooled solution of phosphorus ylide 2e (224 mg, 0.63 mmol) in toluene (26 ml) at -78 °C. After 2 
h at this temperature, the reaction mixture was allowed to reach room temperature overnight. 
Filtration of the obtained suspension afforded a white solid (306 mg, 83 %) which corresponds to 
3e. 
1
H-NMR (400 MHz, CD2Cl2)  7.64 (ddd, J = 0.9, 1.8, 5.0 Hz, 1 H), 7.90-7.85 (m, 6 H), 7.66-
7.61 (m. 3H), 7.52-7.45 (m, 7 H), 7.23-7.21 (m, 1 H), 6.82-6.79 (m, 1 H), 4.5 (d, JH-P  = 7.9 Hz, 1 H) ppm. 
13
C-NMR 
(101 MHz, CD2Cl2) = 161.0 (d, JC-P  = 5.5 Hz), 147.9, 136.5, 134.5 (d, JC-P  = 9.2 Hz), 133.3 (d, JC-P  = 12.1), 125.9 
(d, JC-P  = 87.9), 122.7 (d, JC-P  = 13.1 Hz), 119.3, 29.6 (d, JC-P  = 49.1 Hz)  ppm. 
31
P-NMR (162 MHz, CD2Cl2) = 
28.3 ppm. HRMS calcd. for C31H31N2OAuClPNa: 733.142026; found 733.142583. IR (neat) 
~
= 694, 712, 743, 755, 
767, 854, 918, 946, 997, 1028, 1051, 1102, 1160, 1192, 1212, 1263, 1293, 1357, 1384, 1436, 1488, 1586, 1606, 




Compound 6: A suspension of Phenylisocyanide gold (I) chloride 1a (38 mg, 0.11 mmol) in 
toluene (4.7 ml) was cooled at -10 °C and then the arsenic ylide 5 (41 mg, 0.11 mmol) was 
added. After stirring the obtained suspension for 1 d, the reaction mixture was allowed to 
reach room temperature. The solvents were then filtered out and the remaining a white solid 
washed with small portions of toluene and dried under vacuum. Thus, 6 was obtained as a 
white solid (32 mg, 40%). 
1
H-NMR (400 MHz, CD2Cl2)  14.45 (s, 1 H), 7.85 (d, J = 7.2 Hz, 
6 H), 7.70-7.60 (m, 11H), 7.31 (t, J = 7.7 Hz, 2H), 7.21 (t, J = 7.3 Hz, 1 H), 1.61 (br, 3H) ppm.
 13
C-NMR (75 MHz, 
CD2Cl2) = 198.0, 144.1, 133.3, 133.1, 130.5, 129.1, 129.0, 126.4, 123.4, 31.3 ppm HRMS calcd. for 
C28H24AsAuClNONa: 720.032365; found 720.033071. IR (neat) 
~
=  691, 741, 756, 793, 865, 1014, 1078, 1259, 





Compound 9: A mixture of phenylisocyanide gold (I) chloride 1a (25 mg, 0.08 mmol) and 
diaminoalkene 7 (16 mg, 0.08 mmol) was suspended in toluene (3 ml) and warmed to 35 ºC. 
After 8 h the mixture was allowed to reach room temperature.  Elimination of the solvents by 
filtration afforded pure 9 as a yellow solid (40 mg, 95 % yield). 
1
H-NMR (400 MHz, CD2Cl2) 
 14.73 (s, 1 H), 7.86 (d, J = 7.8 Hz, 2 H), 7.43-7.40 (m, 2 H), 7.35-7.32 (m, 1 H), 7.29-7.25 
(m,3 H), 7.06 (s, 2 H), 7.05-7.03 (m, 2 H) 3.63 (s, 6 H) ppm. 
13
C-NMR (101 MHz, CD2Cl2) = 
194.6, 187.4, 151.5, 143.7, 142.3, 130.2, 129.3, 128.9, 126.2, 125.9, 122.7, 121.3, 98.4, 36.0 ppm. HRMS calcd. 
for C20H19N3OAuClNa: 572.077435; found 572.078099.IR (neat) 
~
= 691, 704, 728, 760, 792, 906, 1025, 1071, 




Compound 10: A mixture of phenylisocyanide gold (I) chloride 1a (26 mg, 0.08 mmol) and diaminoalkene 9 (14 mg, 
0.08 mmol) was suspended in toluene (3.3 ml) and warmed to 35 ºC. After 18 h the mixture was allowed to reach 
room temperature.  Elimination of the solvents by filtration afforded pure 10 as a yellow solid (35 mg, 87 % yield).  
1
H-NMR (400 MHz, CD2Cl2) 12.09 (s, 1 H), 8.32 (d, J = 6.2 Hz, 1H), 8.22 (t, J = 7.9 Hz, 
1 H), 8.16 (d, J = 7.9 Hz, 1 H), 7.78-7.76 (m, 2H), 7.66-7.63 (m, 1H), 7.35-7.32 (m, 2H), 7.18-
7.14 (m, 1 H), 4.17 (s, 3 H), 4.13-4.04 (m, 2 H), 1.15 (t, J = 7.0 Hz, 3 H) ppm. 
13
C-NMR (101 
MHz, CD2Cl2) = 189.6, 165.9, 162.2, 144.2, 143.1, 142.8, 135.3, 129.2, 125.0, 124.4, 122.0, 
98.4, 59.5, 46.2, 14.8 ppm. HRMS calcd. for C17H18N2O2AuClNa: 537.061450; found 
537.061877. IR (neat) ~ = 680, 694, 749, 759, 788, 893, 931, 954, 1028, 1074, 1091, 1175, 




Compound 11 : KOMe (5.5 mg, 0.078 mmol) and [Rh(COD)Cl]2 (19.3 mg, 0.039 
mmol) were suspended in THF (2 ml) and stirred for 10 min, at 5 °C. Then, 4a was 
added and the mixture stirred for 36h. Along this time a light yellow precipitate was 
slowly formed. The reaction was then allowed to reach room temperature and the 
solvent evaporated in vacuo. The yellow solid thus obtained was washed with small 
portions of DCM to afford 11 (54 mg, 72 %). 
1
H-NMR (400 MHz, CDCl3)  8.06-
8.01 (m, 6 H), 7.67-7.57 (m, 9 H), 7.13-7.09 (m, 2 H), 6.97 ( t, J = 7.4 Hz, 1 H), 6.82 (d, J = 7.2 Hz, 2 H), 4.18 (br, 2 
H), 3.33 (br, 2 H), 2.44-2.35 (m, 4 H), 1.83-1.72 (m, 4 H)  1.49 (s, 3 H) ppm.  
13
C-NMR (126 MHz, CDCl3) = 197.6 (d, JC-P  = 35.0 Hz), 180.7 (d, JC-P  = 24.1 Hz), 155.5, 134.1 (d, JC-P  = 8.7 Hz), 
133.1 (d, JC-P  = 2.8 Hz), 129.4 (d, JC-P  = 12.4 Hz), 128.2, 125.5 (d, JC-P  = 91.6 Hz), 124.8, 124.6, 95.3 (d, JC-P  = 
126.6 Hz), 82.7 (d, JC-Rh  = 11.8 Hz), 75.1 (d, JC-Rh  = 11.8 Hz), 53.6,  31.6, 29.6, 28.7 ppm. 
31
P-NMR (162 MHz, 
CDCl3) = 19.9 ppm. IR (neat) 
~
= 687, 708, 725, 741, 759, 776, 800, 869, 911, 964, 998, 1023, 1070, 1096, 1142, 





: 886.075756; found 886.076414. 
 
Compound 12: [RhCp*Cl2]2 (5.0 mg, 0.009 mmol) and 4a (10.2 mg, 0.016 mmol) were 
disolved in DCE (0.2 ml) and NEt3 (0.04 ml, 0.272 mmol) was dropwise added. This solution 
was heated at 50 °C and stirred at this temperature for 4 d. Then, the reaction mixture was 
allowed to cool down to room temperature and filtered in order to remove the formed 
precipitate. The bright red solution thus obtained was evaporated in vacuo affording a red 
solid that was redissolved in a small amount of toluene and filtrated again. Evaporation of the 
toluene produced an orange solid that could be further purified by consecutive crystallizations (2 times from DCM : 
pentane). Thus 11  was obtained as an orange solid (9.0 mg, 83 %). 
1
H-NMR (400 MHz, CDCl3) 7.75-7.66 (m, 6 
H), 7.53-7.50 (m, 3 H), 7.47-7.43 (m, 6 H), 6.96-6.92 (m, 2 H), 6.69 (t, J = 7.2 Hz, 1 H), 6.54 (br, 2 H), 1.36 (s, 3 H), 
1.34 (s, 15 H) ppm. 
13
C-NMR (101 MHz, CDCl3)  200.5 (dd, JC-Rh  =  3.3 Hz, JC-P  = 35.0 Hz), 192.8 (d, JC-P  = 
27.7 Hz), 149.2, 132.6 (d, JC-P  = 9.8 Hz), 130.1 (d, JC-P  = 3.3 Hz), 127.6 (d, JC-P  = 12.4 Hz), 126.6, 126.2 (d, JC-P  = 
93.5 Hz), 121.1, 119.6, 93.6 (d, JC-Rh  = 6.7 Hz), 92.8 (d, JC-P  = 95.8 Hz), 22.1, 8.4 ppm. 
31
P-NMR (162 MHz, 
CDCl3)  11.4 (d, JP-Rh = 2.9 Hz)  ppm. IR (neat) 
~
= 695, 708, 722, 742, 756, 768, 843, 905, 984, 994, 1021, 
1062, 1105, 1119, 1154, 1187, 1225, 1278, 1309, 1353, 1392, 1435, 1473, 1554, 1588, 2911, 3044 cm
-1
. HRMS 
calcd. for C38H39ClNOPRh: 694.150034; found 694.150324. 
 
Compound 13: [Ru(cym)Cl2]2 (10.6 mg, 0.017 mmol) and 4a (22.6 mg, 0.035 mmol) were 
dissolved in DCE (0.7 ml) and then NEt3 (0.08 ml, 0.595 mmol) was added drop wise. The 
reaction mixture was heated at 50 °C and stirred for 1 d. Then, the mixture was allowed to 
cool down to room temperature and filtered. The bright red solution was evaporated in vacuo 
and the remaining orange solids purified by consecutive crystallizations (two times from 
DCM : pentane) to afford 13 (10.0 mg, 41 %) as an orange solid. 
1
H-NMR (400 MHz, CD2Cl2)  7.72 (dd, J = 7.9, 
12.3 Hz, 6 H), 7.56-7.55 (m, 3 H), 7.49-7.47 (m, 6 H), 7.00 (t, J = 7.4 Hz, 2 H), 6.78 (t, J = 7.4 Hz, 1 H), 6.40 (br, 2 
H), 5.42 (d, J = 5.9 Hz, 1 H), 4.96 (d, J = 5.9 Hz, 1 H), 4.70 (d, J = 5.4 Hz, 1 H), 3.77 (d, J = 5.4 Hz, 1 H), 2.42 
(quint. J = 6.8 Hz, 1 H), 1.94 (s, 3 H), 1.28 (s, 3 H), 1.08 (d, J = 6.8 Hz, 3 H), 1.03 (d, J = 6.8 Hz, 3 H) ppm. 
13
C-
NMR (101 MHz, CD2Cl2) = 208.8 (d, JC-P  = 2.8 Hz), 194.9 (d, JC-P = 28.1 Hz), 155.5, 134.2 (d, JC-P = 9.9 Hz), 
132.1 (d, JC-P = 2.9 Hz), 128.9 (d, JC-P = 12.4 Hz), 128.1, 127.3 (d, JC-P = 93.0 Hz), 122.0, 120.8, 102.5, 98.0, 93.2 
(d, JC-P = 97.3 Hz), 91.0, 84.2, 82.1, 76.6, 31.4, 23.2, 22.5, 22.2, 19.0 ppm. 
31
P-NMR (162 MHz, CD2Cl2) = 11.6 
ppm. IR (neat) ~ = 692, 710, 726, 743, 801, 844, 864, 983, 1025, 1103, 1160, 1191, 1260, 1384, 1436, 1472, 1556, 
1589, 1738, 2849, 1917, 2958, 3057 cm
-1
. HRMS calcd. for C38H38ClNOPRu: 692.141123; found 692.141970. 
Selected NMR spectra: 
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P-NMR (162 MHz, CD2Cl2) 3e  
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P-NMR (162 MHz, CD2Cl2) 4a  
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C-NMR (101 MHz, CD2Cl2) 4c 
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P-NMR (162 MHz, CD2Cl2) 4f  
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C-NMR (75 MHz, CD2Cl2) 6 
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Empirical formula  C25 H22 Au Cl3 N P 
Color  colourless 
Formula weight  670.72  g · mol-1 
Temperature  150 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  C2/c,  (no. 15) 
Unit cell dimensions a = 24.4111(6) Å = 90°. 
 b = 8.577(2) Å = 93.067(5)°. 
 c = 23.0774(16) Å  = 90°. 
Volume 4824.8(12) Å3 
Z 8 
Density (calculated) 1.847  Mg · m-3 
Absorption coefficient 6.511 mm-1 
F(000) 2592 e 
Crystal size 0.30 x 0.12 x 0.07 mm3 
 range for data collection 3.05 to 33.10°. 
Index ranges -37  h  37, -13 k  13, -35  l  35 
Reflections collected 67463 
Independent reflections 9159 [Rint = 0.0532] 
Reflections with I>2(I) 7901 
Completeness to  = 27.50° 99.9 % 
Absorption correction Gaussian 
Max. and min. transmission 0.81 and 0.39 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9159 / 0 / 289 
Goodness-of-fit on F2 1.086 
Final R indices [I>2(I)] R1 = 0.0288 wR
2 = 0.0665 
R indices (all data) R1 = 0.0378 wR
2 = 0.0704 











































Empirical formula  C31 H31 Au Cl N2 O P 
Color  colourless 
Formula weight  710.96  g·mol-1  
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  MONOCLINIC 
Space group  p 21/c,  (no. 14)  
Unit cell dimensions a = 16.8854(7) Å = 90°. 
 b = 10.9240(5) Å = 111.3890(10)°. 
 c = 16.4234(7) Å  = 90°. 
Volume 2820.7(2) Å3 
Z 4 
Density (calculated) 1.674  Mg·m-3 
Absorption coefficient 11.412 mm-1 
F(000) 1400 e 
Crystal size 0.14 x 0.13 x 0.10 mm3 
 range for data collection 2.81 to 67.16°. 
Index ranges -18  h  20, -12 k  13, -19 l  19 
Reflections collected 67770 
Independent reflections 4988 [Rint = 0.0481] 
Reflections with I>2(I) 4859 
Completeness to  = 67.16° 99.2 %  
Absorption correction Gaussian 
Max. and min. transmission 0.54295 and 0.22715 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4988 / 0 / 338 
Goodness-of-fit on F2 1.123 
Final R indices [I>2(I)] R1 = 0.0186 wR
2 = 0.0442 
R indices (all data) R1 = 0.0193 wR
2 = 0.0445 




































Empirical formula  C28 H24 Au Cl N O P 
Color  colourless 
Formula weight  653.87  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/c,  (no. 14) 
Unit cell dimensions a = 14.7905(9) Å = 90°. 
 b = 11.9586(10) Å = 115.796(4)°. 
 c = 15.2551(7) Å  = 90°. 
Volume 2429.3(3) Å3 
Z 4 
Density (calculated) 1.788  Mg · m-3 
Absorption coefficient 6.253 mm-1 
F(000) 1272 e 
Crystal size 0.27 x 0.21 x 0.10 mm3 
 range for data collection 2.68 to 37.00°. 
Index ranges -24  h  25, -20 k  20, -25  l  25 
Reflections collected 60767 
Independent reflections 12321 [Rint = 0.0518] 
Reflections with I>2(I) 9429 
Completeness to  = 37.00° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.55184 and 0.21375 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12321 / 0 / 299 
Goodness-of-fit on F2 1.037 
Final R indices [I>2(I)] R1 = 0.0329 wR
2 = 0.0548 
R indices (all data) R1 = 0.0580 wR
2 = 0.0605 












































Empirical formula  C31 H25 Au Cl N2 P·0.5 CH2 Cl2 
Color  yellow 
Formula weight  731.38  g · mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/c,  (no. 14)  
Unit cell dimensions a = 8.7003(3) Å = 90°. 
 b = 19.0210(12) Å = 90.348(4)°. 
 c = 17.8177(14) Å  = 90°. 
Volume 2948.6(3) Å3 
Z 4 
Density (calculated) 1.648  Mg · m-3 
Absorption coefficient 5.248 mm-1 
F(000) 1428 e 
Crystal size 0.17 x 0.10 x 0.09 mm3 
 range for data collection 3.17 to 34.94°. 
Index ranges -14  h  13, -28 k  30, -28  l  28 
Reflections collected 95323 
Independent reflections 12890 [Rint = 0.0388] 
Reflections with I>2(I) 11231 
Completeness to  = 27.50° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.66 and 0.49 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12890 / 0 / 345 
Goodness-of-fit on F2 1.091 
Final R indices [I>2(I)] R1 = 0.0244 wR
2 = 0.0570 
R indices (all data) R1 = 0.0326 wR
2 = 0.0605 







































formula  C28 H24 As Au Cl N O 
Color  colourless 
Formula weight  697.82  g · mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/c,  (no. 14)  
Unit cell dimensions a = 14.9063(15) Å = 90°. 
 b = 12.0478(12) Å = 115.743(3)°. 
 c = 15.3302(3) Å  = 90°. 
Volume 2479.9(4) Å3 
Z 4 
Density (calculated) 1.869  Mg · m-3 
Absorption coefficient 7.385 mm-1 
F(000) 1344 e 
Crystal size 0.20 x 0.17 x 0.07 mm3 
 range for data collection 2.67 to 36.00°. 
Index ranges -24  h  24, -19 k  19, -25  l  25 
Reflections collected 62465 
Independent reflections 11702 [Rint = 0.0491] 
Reflections with I>2(I) 10436 
Completeness to  = 27.50° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.62 and 0.27 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11702 / 0 / 299 
Goodness-of-fit on F2 1.094 
Final R indices [I>2(I)] R1 = 0.0294 wR
2 = 0.0693 
R indices (all data) R1 = 0.0357 wR
2 = 0.0723 
Largest diff. peak and hole 1.897 and -4.624 e · Å-3 




























Empirical formula  C20 H19 Au Cl N3 O 
Color  yellow 
Formula weight  549.80  g · mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/n,  (no. 14)  
Unit cell dimensions a = 12.3447(8) Å = 90°. 
 b = 11.9732(8) Å = 110.926(5)°. 
 c = 13.8197(9) Å  = 90°. 
Volume 1907.9(2) Å3 
Z 4 
Density (calculated) 1.914  Mg · m-3 
Absorption coefficient 7.864 mm-1 
F(000) 1056 e 
Crystal size 0.27 x 0.26 x 0.05 mm3 
 range for data collection 2.76 to 34.99°. 
Index ranges -19  h  19, -19 k  19, -22  l  22 
Reflections collected 55520 
Independent reflections 8346 [Rint = 0.0311] 
Reflections with I>2(I) 7679 
Completeness to  = 34.99° 99.4 %  
Absorption correction Gaussian 
Max. and min. transmission 0.69 and 0.14 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8346 / 0 / 237 
Goodness-of-fit on F2 1.172 
Final R indices [I>2(I)] R1 = 0.0157 wR
2 = 0.0432 
R indices (all data) R1 = 0.0192 wR
2 = 0.0450 






Empirical formula  C37 H37 Au Cl3 N O P Rh 
Color  orange 
Formula weight  948.87  g · mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/c,  (no. 14)  
Unit cell dimensions a = 15.2528(12) Å = 90°. 
 b = 12.7151(19) Å = 101.855(11)°. 
 c = 17.885(4) Å  = 90°. 
Volume 3394.7(10) Å3 
Z 4 
Density (calculated) 1.857  Mg · m-3 
Absorption coefficient 5.118 mm-1 
F(000) 1856 e 
Crystal size 0.14 x 0.12 x 0.06 mm3 
 range for data collection 2.729 to 33.218°. 
Index ranges -23  h  23, -19 k  19, -25  l  27 
Reflections collected 58509 
Independent reflections 12950 [Rint = 0.0360] 
Reflections with I>2(I) 11849 
Completeness to  = 25.242° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.75 and 0.51 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12950 / 0 / 407 
Goodness-of-fit on F2 1.096 
Final R indices [I>2(I)] R1 = 0.0294 wR
2 = 0.0676 
R indices (all data) R1 = 0.0342 wR
2 = 0.0698 
Extinction coefficient n/a 


























































































Empirical formula  C38 H38 Cl1 N1 O1 P1 Rh1 
Color  orange 
Formula weight  694.02  g · mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/c,  (no. 14)  
Unit cell dimensions a = 10.7983(10) Å = 90°. 
 b = 13.1084(12) Å = 100.263(2)°. 
 c = 23.391(2) Å  = 90°. 
Volume 3258.0(5) Å3 
Z 4 
Density (calculated) 1.415  Mg · m-3 
Absorption coefficient 0.686 mm-1 
F(000) 1432 e 
Crystal size 0.15 x 0.12 x 0.08 mm3 
 range for data collection 1.77 to 33.31°. 
Index ranges -16  h  16, -20 k  20, -35  l  36 
Reflections collected 107131 
Independent reflections 12543 [Rint = 0.0424] 
Reflections with I>2(I) 10641 
Completeness to  = 27.50° 100.0 %  
Absorption correction Gaussian 
Max. and min. transmission 0.77 and 0.54 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12543 / 0 / 394 
Goodness-of-fit on F2 1.114 
Final R indices [I>2(I)] R1 = 0.0233 wR
2 = 0.0596 
R indices (all data) R1 = 0.0333 wR
2 = 0.0684 
Largest diff. peak and hole 0.535 and -0.498 e · Å-3 
 
